Mufg Securities Americas Inc. Makes New Investment in DaVita Inc. (NYSE:DVA)

Mufg Securities Americas Inc. acquired a new position in shares of DaVita Inc. (NYSE:DVA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 666 shares of the company’s stock, valued at approximately $100,000.

Several other institutional investors have also recently bought and sold shares of DVA. SBI Securities Co. Ltd. acquired a new position in DaVita during the fourth quarter worth $41,000. Coppell Advisory Solutions LLC raised its holdings in shares of DaVita by 50.0% in the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock valued at $45,000 after purchasing an additional 100 shares during the last quarter. Canada Post Corp Registered Pension Plan purchased a new stake in shares of DaVita in the fourth quarter valued at about $55,000. Venturi Wealth Management LLC raised its holdings in shares of DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after purchasing an additional 152 shares during the last quarter. Finally, Blue Trust Inc. raised its holdings in shares of DaVita by 39.7% in the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after purchasing an additional 131 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Price Performance

DVA opened at $145.23 on Friday. The firm has a market cap of $11.16 billion, a P/E ratio of 13.52, a PEG ratio of 1.07 and a beta of 1.14. The firm has a 50-day moving average of $145.68 and a 200 day moving average of $153.48. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita Inc. has a fifty-two week low of $131.44 and a fifty-two week high of $179.60.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.25. The company had revenue of $3.22 billion during the quarter, compared to analyst estimates of $3.22 billion. DaVita had a net margin of 7.31% and a return on equity of 115.48%. The firm’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.26 earnings per share. On average, research analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on DVA shares. StockNews.com upgraded shares of DaVita from a “hold” rating to a “buy” rating in a report on Friday, April 25th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. Cowen reiterated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Barclays increased their target price on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.